SINGAPORE - People waiting for Covid-19 swab test results may experience delays beyond 24 hours because laboratories are experiencing a surge in the number of swabs being sent in daily, said Parkway Laboratories chief executive Daniel Tan. He said the daily average number of swabs received in the past two weeks was almost double that from a month ago. He.
The New Paper
Innoquest Diagnostics has seen a threefold spike in swabs daily since May 17. PHOTO: LIANHE ZAOBAO
Demand has surged significantly amid rise in Covid-19 testing
0 Engagements
Laboratories in Singapore are operating at more than 80 per cent capacity to meet the recent demand for polymerase chain reaction (PCR) tests amid the surge in Covid-19 testing.
As at May 25, there are 27 laboratories that conduct Covid-19 tests in Singapore and can do up to 70,000 tests daily, the Ministry of Health (MOH) said.
They support the PCR testing requirements in the hospitals, clinics, regional screening centres (RSCs), dormitories and all testing operations mounted for active case finding, and screening purposes.
Singapore's Big Plan; Prizes for Vaccinated People: Virus Update leaderpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from leaderpost.com Daily Mail and Mail on Sunday newspapers.
Singapore enhances neutralizing antibody testing service
Singapore enhances neutralizing antibody testing service 12 April 2021 | News
Image credit- prnewswire
GenScript Biotech Corporation, Parkway Laboratories and the Diagnostics Development (DxD) Hub announced their collaboration to provide the cPass™ SARS-CoV-2 neutralizing antibody test in Singapore through Parkway s panel of specialist and GP clinics.
Neutralizing antibodies are a small percentage of antibodies that bind to sites on the virus and inhibit entry of that virus into the host. Unlike the many COVID-19 lab-based antibody test kits commercially available, cPass™ can detect functional neutralizing antibodies.
Traditionally, measuring neutralizing antibodies requires the use of live virus, cells, highly skilled operators, and complex laboratory procedures that require several days in the laboratory to obtain results and limit their widespread use.